Literature DB >> 17188054

Intraoperative sclerotomy-related retinal breaks for macular surgery, 20- vs 25-gauge vitrectomy systems.

Richard Scartozzi1, Amr S Bessa, Omesh P Gupta, Carl D Regillo.   

Abstract

PURPOSE: To compare the rate of intraoperative sclerotomy-related retinal breaks (SRRB) between 20- and 25-gauge vitrectomy systems for the correction of macular pucker (MP) and macular hole (MH).
DESIGN: Retrospective interventional case series.
METHODS: Single institution review of 347 consecutive eyes of 333 patients between August 2003 and May 2005 receiving pars plana vitrectomy (PPV) for MP or MH repair. Eyes were excluded if they had any form of proliferative retinopathy, or if there was an intraoperative conversion of any sclerotomy from 25- to 20- gauge.
RESULTS: Fourteen (6.4%) of 219 eyes in the 20-gauge group had SRRB vs 4 (3.1%) of 128 eyes in the 25-gauge group (Fisher exact test, P value = .22).
CONCLUSIONS: There was a trend for slightly lower rates of intraoperative sclerotomy-related retinal breaks, single or multiple, with 25-gauge PPV compared with 20-gauge PPV, but the differences were not statistically significant.

Entities:  

Mesh:

Year:  2006        PMID: 17188054     DOI: 10.1016/j.ajo.2006.07.038

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  22 in total

1.  Iatrogenic retinal breaks and postoperative retinal detachments in microincision vitrectomy surgery compared with conventional 20-gauge vitrectomy: a meta-analysis.

Authors:  G H Chen; R Tzekov; F Z Jiang; S H Mao; Y H Tong; W S Li
Journal:  Eye (Lond)       Date:  2018-12-18       Impact factor: 3.775

2.  Intraoperative iatrogenic peripheral retinal break in 23-gauge transconjunctival sutureless vitrectomy versus 20-gauge conventional vitrectomy.

Authors:  Dong Min Cha; Se Joon Woo; Kyu Hyung Park; Hum Chung
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-16       Impact factor: 3.117

3.  Comparison of microinsicion vitrectomy and conventional 20-gauge vitrectomy for severe proliferative diabetic retinopathy.

Authors:  Reiji Yokota; Makoto Inoue; Yuji Itoh; Tosho Rii; Kazunari Hirota; Akito Hirakata
Journal:  Jpn J Ophthalmol       Date:  2015-07-23       Impact factor: 2.447

4.  Pars plana vitrectomy for disturbing primary vitreous floaters: clinical outcome and patient satisfaction.

Authors:  Karlijn F de Nie; N Crama; Maurits A D Tilanus; B Jeroen Klevering; Camiel J F Boon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-19       Impact factor: 3.117

Review 5.  25th RCOphth Congress, President's Session paper: 25 years of progress in vitreoretinal surgery.

Authors:  G W Aylward
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

Review 6.  Iatrogenic retinal traumas in ophthalmic surgery.

Authors:  Daniele Tognetto; Maria Teresa di Lauro; Daniela Fanni; Adelia Zagidullina; Luca Michelone; Giuseppe Ravalico
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-07-05       Impact factor: 3.117

7.  Non-vitrectomizing surgery for idiopathic macular pucker using a 25-gauge synergetics high-flow infusion with a 27-gauge light (Photon II, Synergetics USA, Inc.).

Authors:  Cesare Mariotti; Francesca Viti; Piergiorgio Neri
Journal:  Int Ophthalmol       Date:  2009-09-02       Impact factor: 2.031

8.  Comparison of retinal breaks observed during 23 gauge transconjunctival vitrectomy versus conventional 20 gauge surgery for proliferative diabetic retinopathy.

Authors:  Sharif A Issa; Alan Connor; Maged Habib; David Hw Steel
Journal:  Clin Ophthalmol       Date:  2011-01-20

9.  Small gauge vitrectomy: Recent update.

Authors:  Sumeet Khanduja; Ashish Kakkar; Saptrishi Majumdar; Rajpal Vohra; Satpal Garg
Journal:  Oman J Ophthalmol       Date:  2013-01

10.  Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) study: findings at 3 months.

Authors:  Rahul K Reddy; Maziar Lalezary; Stephen J Kim; Jeffrey A Kammer; Rachel W Kuchtey; Edward F Cherney; Franco M Recchia; Karen M Joos; Anita Agarwal; Janice C Law
Journal:  Clin Ophthalmol       Date:  2013-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.